NCT07023731
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07023731
Title A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Arvinas Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Clinical Trial Site Phoenix Arizona 85004 United States Details
Clinical Trial Site Phoenix Arizona 85054 United States Details
Clinical Trial Site New Haven Connecticut 06510 United States Details
Clinical Trial Site Tampa Florida 33612 United States Details
Clinical Trial Site Indianapolis Indiana 46250 United States Details
Clinical Trial Site Grand Rapids Michigan 49546 United States Details
Clinical Trial Site New York New York 10032 United States Details
Clinical Trial Site New York New York 10065 United States Details
Clinical Trial Site Huntersville North Carolina 28078 United States Details
Clinical Trial Site Cleveland Ohio 44106 United States Details
Clinical Trial Site Houston Texas 77030-7009 United States Details
Clinical Trial Site San Antonio Texas 78229 United States Details
Clinical Trial Site Salt Lake City Utah 84112 United States Details
Clinical Trial Site Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field